The Effect of Testosterone Topical Solution (LY900011) in Hypogonadal Men With Suboptimal Response to a Topical Testosterone Gel
Phase of Trial: Phase IV
Latest Information Update: 30 Jan 2015
At a glance
- Drugs Testosterone (Primary)
- Indications Hypogonadism
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 16 Jan 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 11 Dec 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 21 Oct 2013 Planned End Date changed from 1 Nov 2014 to 1 Jan 2014 as reported by ClinicalTrials.gov.